Evidence map›Paper›PMID 37300586›Full record

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2023

Lupus nephritis or not? A simple and clinically friendly machine learning pipeline to help diagnosis of lupus nephritis.

Da-Cheng Wang, Wang-Dong Xu, Shen-Nan Wang, Xiang Wang, Wei Leng, Lu Fu, Xiao-Yan Liu, Zhen Qin, An-Fang Huang

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07780045 (Emerging Inflammatory Biomarkers), which is not on this map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07780045 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Emerging Inflammatory Biomarkers (SII and SIRI) for Predicting Disease Activity, Renal Flares and Outcomes in Lupus Nephritis: A Prospective Observational Study

Typeobservational_patient_registrySponsorAssiut UniversityRan2026 to 2027Enrolled100ConditionsLupus Nephritis, Systemic Lupus Erythematosus, Kidney Diseases
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Da-Cheng Wang *Department of Evidence-Based Medicine, Southwest Medical University, 1 Xianglin Road, Luzhou, Sichuan, China.
Wang-Dong Xu *Department of Evidence-Based Medicine, Southwest Medical University, 1 Xianglin Road, Luzhou, Sichuan, China.
Shen-Nan WangLuzhou Meteorological Bureau, 3 Songshan Road, Luzhou, Sichuan, China.
Xiang WangLuzhou Meteorological Bureau, 3 Songshan Road, Luzhou, Sichuan, China.
Wei LengLuzhou Meteorological Bureau, 3 Songshan Road, Luzhou, Sichuan, China.
Lu FuLaboratory Animal Center, Southwest Medical University, 1 Xianglin Road, Luzhou, Sichuan, China.
Xiao-Yan LiuDepartment of Evidence-Based Medicine, Southwest Medical University, 1 Xianglin Road, Luzhou, Sichuan, China.
Zhen QinDepartment of Rheumatology and Immunology, Affiliated Hospital of Southwest Medical University, 25 Taiping Road, Luzhou, Sichuan, China.
An-Fang HuangDepartment of Rheumatology and Immunology, Affiliated Hospital of Southwest Medical University, 25 Taiping Road, Luzhou, Sichuan, China. loutch211@163.com.
Southwest Medical University · CNAffiliated Hospital of Southwest Medical University · CN

Funding

Natural Science Foundation of Sichuan Province 2022NSFSC0694Natural Science Foundation of Sichuan Province 2022NSFSC0697
6 · The paper itself

Abstract

objectiveDiagnosis of lupus nephritis (LN) is a complex process, which usually requires renal biopsy. We aim to establish a machine learning pipeline to help diagnosis of LN.

methodsA cohort of 681 systemic lupus erythematosus (SLE) patients without LN and 786 SLE patients with LN was established, and a total of 95 clinical, laboratory data and 17 meteorological indicators were collected. After tenfold cross-validation, the patients were divided into training set and test set. The features selected by collective feature selection method of mutual information (MI) and multisurf were used to construct the models of logistic regression, decision tree, random forest, naive Bayes, support vector machine (SVM), light gradient boosting (LGB), extreme gradient boosting (XGB), and artificial neural network (ANN), the models were compared and verified in post-analysis.

resultsCollective feature selection method screens out antistreptolysin (ASO), retinol binding protein (RBP), lupus anticoagulant 1 (LA1), LA2, proteinuria and other features, and the hyperparameter optimized XGB (ROC: AUC = 0.995; PRC: AUC = 1.000, APS = 1.000; balance accuracy: 0.990) has the best performance, followed by LGB (ROC: AUC = 0.992; PRC: AUC = 0.997, APS = 0.977; balance accuracy: 0.957). The worst performance is naive Bayes model (ROC: AUC = 0.799; PRC: AUC = 0.822, APS = 0.823; balance accuracy: 0.693). In the composite feature importance bar plots, ASO, RF, Up/Ucr, and other features play important roles in LN.

conclusionWe developed and validated a new and simple machine learning pathway for diagnosis of LN, especially the XGB model based on ASO, LA1, LA2, proteinuria, and other features screened out by collective feature selection.

Indexed as

Lupus Erythematosus, SystemicLupus NephritisBayes TheoremHumansMachine LearningProteinuriaLupus nephritisMachine learningMeteorological dataSLE

Identifiers

PMID37300586
PMCPMC10257380
OpenAlexW4380184406

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.